Clinical Trial Update: Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating docetaxel plus hydroxychloroquine in metastatic prostate cancer was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-11-25